Supplementation of Glucomannan Derived from Konjac Flour Improve Glucose Homeostasis and Reduce Insulin Resistance in Diabetes Rat Models
DOI:
https://doi.org/10.3923/pjn.2015.913.918Keywords:
Diabetes, glucose homeostasis, insulin resistance, konjac flourAbstract
Dietary fiber from glucomannan has been studied to decrease blood glucose concentration, but its mechanism in diabetes is still unclear. The aim of our research is to study the effect of glucomannan, derived from konjac flour, in rat models of diabetes including gastrointestinal function, inhibition of DPP-IV enzyme and reducing in insulin resistance. A total of 25 male wistar rats were divided into 5 groups; normal group (Normal), diabetes group (DM), diabetes group administered with 100 mg/kg BW konjac flour (DM+KF1), 200 mg/kg BW konjac flour (DM+KF2) and 400 mg/kg BW konjac flour (DM+KF3). Diabetes was induced by a combination of 60% high fructose diet and twice intraperitoneal injection of streptozotocin (25 and 30 mg/kg BW) at one week interval. Konjac flour was given according to each dose for 4 weeks. At the end of the study, blood and tissue sample were collected for subsequent analysis, while isolated intestine used to measure jejunal serous glucose concentration using everted sac technique. The results indicate that glucomannan reduced fasting blood glucose levels, improved glucose tolerance, increased jejunal serous glucose concentration at in vitro technique and decreased insulin resistance as evidenced by a decreased in HOMA-IR index and increased in PI3K levels. However, glucomannan not decreased DPP-4 levels in any dose. This results indicate that glucomannan derived from Konjac flour had antidiabetic effects through improving in glucose homeostasis and reducing in insulin resistance in rat models of diabetes.
References
American Diabetes Association, 2013. Diagnosis and classification of diabetes mellitus. Diabetes Care, 36: S67-S74.
Adeniyi, K.O. and M.O. Oloowookurun, 1987. Intestinal fluid and glucose transport in rats: Effects of thyroidectomy and thyroxin administration. Niger. J. Physiol. Sci., 3: 61-66.
Augustyns, K., P. van der Veken, K. Senten and A. Haemers, 2005. The therapeutic potential of inhibitors of dipeptidyl peptidase IV (DPP IV) and related proline-specific dipeptidyl aminopeptidases. Curr. Med. Chem., 12: 971-998.
Den Besten, G., K. van Eunen, A.K. Groen, S.K. Venema, D.J. Reijngoud and B.M. Bakker, 2013. The role of short-chain fatty acids in the interplay between diet, gut microbiota and host energy metabolism. J. Lipid Res., 54: 2325-2340.
Butler, L.K., 1995. Regulation of Blood Glucose Levels in Normal and Diabetic Rats. In: Tested Studies for Laboratory Teaching, Goldman, C.A., P.L. Hauta, M.A. O'Donnell, S.A. Andrews and R. van der Heiden (Eds.). University of Texas-Austin, Austin, Texas, pp: 181-202.
Chearskul, S., S. Sangurai, W. Nitiyanant, W. Kriengsinyos, S. Kooptiwut and T. Harindhanavudhi, 2007. Glycemic and lipid responses to glucomannan in Thais with type 2 diabetes mellitus. J. Med. Assoc. Thai, 90: 2150-2157.
Cameron-Smith, D., R. Habito, M. Barnett and G.R. Collier, 1997. Dietary guar gum improves insulin sensitivity in streptozotocin-induced diabetic rats. J. Nutr., 127: 359-364.
Chen, H.L., H.C. Cheng, W.T. Wu, Y.J. Liu and S.Y. Liu, 2008. Supplementation of konjac glucomannan into a low-fiber chinese diet promoted bowel movement and improved colonic Ecology in constipated adults: A placebo-controlled, diet-controlled trial. J. Am. Coll. Nutr., 27: 102-108.
DeBosch, B.J., Z. Chen, B.N. Finck, M. Chi and K.H. Moley, 2013. Glucose transporter-8 (GLUT8) mediates glucose intolerance and dyslipidemia in high-fructose diet-fed male mice. Mol. Endocrinol., 27: 1887-1896.
Hannan, J.M.A., L. Ali, B. Rokeya, J. Khaleque and M. Akhter et al., 2007. Soluble dietary fibre fraction of Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption and enhancing insulin action. Br. J. Nutr., 97: 514-521.
Higgins, J.A., D.R. Higbee, W.T. Donahoo, I.L. Brown, M.L. Bell and D.H. Bessesen, 2004. Resistant starch consumption promotes lipid oxidation. Nutr. Metab., Vol. 8.
Holford, P., 2010. Say No to Diabetes. Hachette, United Kingdom.
Keithley, J. and B. Swanson, 2005. Glucomannan and obesity: A critical review. Altern. Therapies Health Med., 11: 30-34.
Kimura, I., K. Ozawa, D. Inoue, T. Imamura and K. Kimura et al., 2013. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun., Vol. 4.
Koroskenyi, B. and S.P. McCarthy, 2001. Synthesis of acetylated konjac glucomannan and effect of degree of acetylation on water absorbency. Biomacromolecules, 2: 824-826.
Leclere, C.J., M. Champ, J. Boillot, G. Guille and G. Lecannu et al., 1994. Role of viscous guar gums in lowering the glycemic response after a solid meal. Am. J. Clin. Nutr., 59: 914-921.
Li, C., Y. Wang, W. He and B. Xie, 2004. [Studies on the antidiabetic effect of konjac glucomannan with different molecular chains on experimental diabetes mice]. J. Chin. Med. Mater., 27: 110-113, (In Chinese).
Makdissi, A., H. Ghanim, M. Vora, K. Green and S. Abuaysheh et al., 2012. Sitagliptin exerts an antinflammatory action. J. Clin. Endocrinol. Metab., 97: 3333-3341.
Nasir, O., F. Artunc, K. Wang, R. Rexhepaj and M. Foller et al., 2010. Downregulation of mouse intestinal Na+-coupled glucose transporter SGLT1 by gum Arabic (Acacia senegal). Cell. Physiol. Biochem., 25: 203-210.
Pandey, M. and Vijayakumar, 2011. Nutraceutical supplementation for diabetes: A review. Int. J. Pharm. Pharmaceut. Sci., 3: 33-40.
Psichas, A., M.L. Sleeth, K.G. Murphy, L. Brooks and G.A. Bewick et al., 2015. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int. J. Obesity, 39: 424-429.
Puddu, A., R. Sanguineti, F. Montecucco and G.L. Viviani, 2014. Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes. Mediators Inflamm.
Robertson, M.D., A.S. Bickerton, A.L. Dennis, H. Vidal and K.N. Frayn, 2005. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am. J. Clin. Nutr., 82: 559-567.
Thornberry, N.A. and B. Gallwitz, 2009. Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4). Best Pract. Res. Clin. Endocrinol. Metab., 23: 479-486.
Tolhurst, G., H. Heffron, Y.S. Lam, H.E. Parker and A.M. Habib et al., 2012. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes, 61: 364-371.
Wilson, T.H. and G. Wiseman, 1954. The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface. J. Physiol., 123: 116-125.
Zhang, M., X.Y. Lv, J. Li, Z.G. Xu and L. Chen, 2008. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp. Diabetes Res., Vol. 2008.
IDF., 2013. IDF Diabetes Atlas. 6th Edn., International Diabetes Federation, Brussels, Belgium.
Downloads
Published
Issue
Section
License
Copyright (c) 2015 Asian Network for Scientific Information
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
